Cargando…
P1450: VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430443/ http://dx.doi.org/10.1097/01.HS9.0000972684.00362.84 |
| _version_ | 1785090965330984960 |
|---|---|
| author | Konté, Kadère Gaartman, Aafke van Zwieten, Rob Veldthuis, Martijn van Bruggen, Robin Biemond, Bart Nur, Erfan |
| author_facet | Konté, Kadère Gaartman, Aafke van Zwieten, Rob Veldthuis, Martijn van Bruggen, Robin Biemond, Bart Nur, Erfan |
| author_sort | Konté, Kadère |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430443 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104304432023-08-17 P1450: VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES Konté, Kadère Gaartman, Aafke van Zwieten, Rob Veldthuis, Martijn van Bruggen, Robin Biemond, Bart Nur, Erfan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430443/ http://dx.doi.org/10.1097/01.HS9.0000972684.00362.84 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Konté, Kadère Gaartman, Aafke van Zwieten, Rob Veldthuis, Martijn van Bruggen, Robin Biemond, Bart Nur, Erfan P1450: VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES |
| title | P1450: VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES |
| title_full | P1450: VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES |
| title_fullStr | P1450: VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES |
| title_full_unstemmed | P1450: VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES |
| title_short | P1450: VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES |
| title_sort | p1450: voxelotor treatment leads to improved viability of sickle erythrocytes |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430443/ http://dx.doi.org/10.1097/01.HS9.0000972684.00362.84 |
| work_keys_str_mv | AT kontekadere p1450voxelotortreatmentleadstoimprovedviabilityofsickleerythrocytes AT gaartmanaafke p1450voxelotortreatmentleadstoimprovedviabilityofsickleerythrocytes AT vanzwietenrob p1450voxelotortreatmentleadstoimprovedviabilityofsickleerythrocytes AT veldthuismartijn p1450voxelotortreatmentleadstoimprovedviabilityofsickleerythrocytes AT vanbruggenrobin p1450voxelotortreatmentleadstoimprovedviabilityofsickleerythrocytes AT biemondbart p1450voxelotortreatmentleadstoimprovedviabilityofsickleerythrocytes AT nurerfan p1450voxelotortreatmentleadstoimprovedviabilityofsickleerythrocytes |